Key facts
- It has raised $3.2M; the latest was Seed Round ($3.2M) in Oct 2025.
- Notable investors include Creative Destruction Lab, University of Toronto, University of Toronto Entrepreneurship, MaRS Discovery District, GreenSky Ventures — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for PhenoTips
- ·The full record, as it builds
Funding rounds
No funding rounds for PhenoTips are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PhenoTips
Developer of a genomic health record software designed to offer existing electronic health records for clinical use. The company's software unifies genomic workflows to improve diagnostic accuracy and standardize phenotype recording with an automated pedigree drawing and cancer risk assessment, enabling doctors to use genomic medicine in clinical decision-making and diagnosis.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2014
- Employees
- 23
- Website
- phenotips.com/
- Ownership
- Privately Held (backing)
PhenoTips doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PhenoTips shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PhenoTips in its N-PORT filings yet. We sweep new filings monthly.